November 10, 2022 — Biosense Webster, Inc., the global leader in cardiac arrhythmia treatment and part of Johnson & ...
November 10, 2022 — A national study led by UBC researchers at the Centre for Cardiovascular Innovation is shedding ...
November 10, 2022 — Researchers at the University of Maryland School of Medicine’s (UMSOM) Center for Precision Disease ...
This case study from Change Healthcare presents the following: Customer: Washington Health System Washington, PA ...
November 10, 2022 – Significant findings from the clinical trial, known as “BEST-CLI — Best Endovascular versus Best ...
November 9, 2022 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), left ...
November 9, 2022 — Lexicon Pharmaceuticals, Inc. announced that a new analysis of results from the SOLOIST-WHF Phase 3 ...
Discover the key features of cardiovascular structured reporting that drive adoption, including automated data flow, EHR ...
November 9, 2022 — CinCor Pharma, Inc. announced the presentation today of Phase 2 data from its BrigHtn trial as part ...

The world market for interventional X-ray and mobile C-arm equipment is forecast to reach over $4.9 billion by 2026 ...

November 9, 2022 — Seven awardees were honored during the American Heart Association Scientific Sessions (AHA 2022). The ...
The optimal delivery of cardiac care is evolving rapidly. A growing number of patients combined with innovative new ...

Interventional cardiologists know well the phrase “change is the only constant.” This is especially relevant as ...

Numerous indicators make clear that the next five years will usher in extreme transformation for a multitude of ...
Reflecting back, 2022 has been a productive year. It brought with it many changes and challenges, but also brought back ...
New research shows superiority of Ultromics’ AI in predicting cardiac-related death As the use of artificial ...
November 8, 2022 — Genomic-based therapies for cardiovascular disease are emerging fast in research, and could soon be ...
November 8, 2022 — After hospital discharge for heart failure, people treated with either loop diuretic medication ...
November 8, 2022 — A single IV infusion of NTLA-2001, a novel CRISPR/Cas9-based gene editing therapy, significantly ...